A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer

被引：6
|
作者：
Wang, Weili [1 ]
Liao, Ping [1 ]
He, Yijing [1 ,2 ]
机构：
[1] Cent S Univ, Dept Clin Pharmacol, Inst Clin Pharmacol, Xiangya Hosp, Xiangya Rd 110, Changsha 410000, Hunan, Peoples R China
[2] Xiangya Hosp, Dept Dermatol, Hunan Key Lab Skin Canc & Psoriasis, Xiangya Rd 110, Changsha 410000, Hunan, Peoples R China
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 2017年 / 66卷 / 10期
基金：
中国国家自然科学基金;
关键词：
BINDING;
D O I：
10.1007/s00262-017-2017-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1379 / 1381
页数：3
相关论文
共 50 条
  • [21] PD-L1 Expression in Pancreatic Cancer
    Zheng, Lei
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (06)
  • [22] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [23] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [24] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [25] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    [J]. CANCER RESEARCH, 2016, 76
  • [26] PD-L1 Protein Expression and PD-L1 Gene Amplification in Urothelial Carcinoma of the Urinary Bladder
    Zuo, Chunlai
    Kallakury, Bhaskar V. S.
    Firestone, Bryan
    Voronel, Olga
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey S.
    [J]. MODERN PATHOLOGY, 2016, 29 : 272A - 272A
  • [27] PD-L1 Protein Expression and PD-L1 Gene Amplification in Urothelial Carcinoma of the Urinary Bladder
    Zuo, Chunlai
    Kallakury, Bhaskar V. S.
    Firestone, Bryan
    Voronel, Olga
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey S.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 272A - 272A
  • [28] PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients
    Krawczyk, Pawel
    Grenda, Anna
    Wojas-Krawczyk, Kamila
    Nicos, Marcin
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Reszka, Katarzyna
    Pankowski, Juliusz
    Krukowska, Kinga
    Bozyk, Aleksandra
    Szumilo, Justyna
    Sawicki, Marek
    Trojanowski, Tomasz
    Milanowski, Janusz
    [J]. CANCER GENETICS, 2019, 237 : 10 - 18
  • [29] Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression
    Pyo, Jung-Soo
    Ko, Soo Hee
    Ko, Young San
    Kim, Nae Yu
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [30] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Festino, Lucia
    Botti, Gerardo
    Lorigan, Paul
    Masucci, Giuseppe V.
    Hipp, Jason D.
    Horak, Christine E.
    Melero, Ignacio
    Ascierto, Paolo A.
    [J]. DRUGS, 2016, 76 (09) : 925 - 945
12345